Original Source(s)
Related Content
OI Therapy Raised BMD, Not Fracture Benefit
Teriparatide followed by zoledronic acid increased bone mineral density but did not reduce fracture risk compared with standard care in adults with osteogenesis imperfecta.
June 5, 2026
-
7 min